LABORATORY INVESTIGATION OF SUSPECTED MYELOMA Introduction
Procedure Initial
laboratory investigations should include:
Follow up tests will be done automatically depending on the abnormalities found. Paraproteins will be typed and quantitated; positive screening tests for Bence Jones protein will be confirmed; and if required bone marrow studies will be performed by the Haematologists. Radiological investigations will also need to be organised. Discussion About
80% of paraproteins - monoclonal immunoglobulins - are due to malignancy,
and approximately 65% of these are due to multiple myeloma.
Around 20% of myeloma patients produce only Bence Jones proteins
(free light chains) and these are rapidly cleared in the urine in the
early stages of the disease, so a urine screen must be done.
Roughly 80% of those with a serum band also have Bence Jones
proteinuria. A few myeloma
patients are non-secretors, i.e. they produce no detectable immunoglobulin
molecule or fragment. High
paraprotein level, suppression of normal immunoglobulin production, and
Bence Jones proteinuria are indicators of a poor prognosis. Monoclonal
immunoglobulins may be seen in other lymphoid cell tumours, as well as in
apparently benign cases (MGUS). The
incidence of paraproteinaemia increases with age - it is nearly 10% in
those over the age of 80 years. Faint
monoclonal or oligoclonal immunoglobulins may also appear as a transient
phenomenon in intense immune reactions.
Usually in these cases, there will also be a raised level of
‘normal’ immunoglobulins.
Reviewed by:
John Surrey, Principal Biochemist
|